Sanofi announced a definitive agreement to acquire Blueprint Medicines Corporation, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and other KIT-driven diseases. This...
Sanofi announced the successful completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, a privately held, clinical-stage biopharmaceutical...
Recipharm, a global leader in contract development and manufacturing (CDMO), has announced a strategic partnership with ProductLife Group (PLG), a prominent provider of product...
AIRNA, a biotech company pioneering RNA editing therapeutics to transform the lives of patients with rare and common conditions, announced the appointment of Jacob...
Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and design, announced a collaboration and license agreement with Eli Lilly...
